ALKEM
Alkem Laboratories Ltd.
Latest scanner signal, chart levels and stage timeline for ALKEM. Research only, not advice.
Copied
Latest status
Pre-Breakout
Weak
Scan date 2026-05-11
₹5585.0
Latest price
5.0
Latest scanner score
8
Saved appearances
large_mid
Healthcare
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Daily Chart
Levels are generated from the latest scanner row.
Results & Fundamentals Lens
Steady cadence
Latest quarterly snapshot saved for ALKEM. Use it with price action, not as standalone advice.
Acceleration
Stable
Quarter ended 2025-12-31
Revenue YoY
Top-line growth vs same quarter last year
+10.7%
Revenue QoQ
Sequential sales momentum
-6.6%
EPS YoY
Profit growth vs same quarter last year
+1.6%
EPS QoQ
Sequential earnings momentum
-16.9%
What to notice
Growth is not explosive — lean more on structure, volume, and market tone; the tape matters more than the print.
YoY and QoQ deltas benchmark the latest reported quarter ending 2025-12-31.
Detailed Scanner Breakdown
Detailed fields from the latest pre-breakout row.
Weak · 5.0
Price
₹5585.0
Stage
Unknown
RS trend
–
Sector RS
0.0%
Base
–
Base quality
–
Vol quality
–
Failure risk
–
RS rank
–
RSI
47.4
ADX
15.7
Avg value
–
Distribution
0 day(s)
VCP
–
Vol dry
No
Flags
None
Scanner Notes
✓ SKIP: 50DMA below 150DMA (5438.61 <= 5560.10)
Related Stocks
Same sector or industry, ranked by latest pre-breakout score.
NATCOPHARM
NATCO Pharma Ltd.
Very Strong
88.9
TORNTPHARM
Torrent Pharmaceuticals Ltd.
Very Strong
84.3
STAR
Strides Pharma Science Ltd.
Very Strong
82.8
LAURUSLABS
Laurus Labs Ltd.
Very Strong
81.9
YATHARTH
Yatharth Hospital & Trauma Care Services Ltd.
Very Strong
81.2
AUROPHARMA
Aurobindo Pharma Ltd.
Strong
79.2
ASTERDM
Aster DM Healthcare Ltd.
Strong
78.5
GLENMARK
Glenmark Pharmaceuticals Ltd.
Strong
75.8